Please wait while the formulary information is being retrieved.
Drug overview for OMNISCAN (gadodiamide):
Generic name: GADODIAMIDE
Drug class:
Therapeutic class: Diagnostic Agents
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: GADODIAMIDE
Drug class:
Therapeutic class: Diagnostic Agents
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
- OMNISCAN 287 MG/ML VIAL
The following indications for OMNISCAN (gadodiamide) have been approved by the FDA:
Indications:
Diagnostic imaging
Professional Synonyms:
Diagnostic imaging exam
Diagnostic imaging procedure
Diagnostic radiography
Diagnostic radiology
Indications:
Diagnostic imaging
Professional Synonyms:
Diagnostic imaging exam
Diagnostic imaging procedure
Diagnostic radiography
Diagnostic radiology
The following dosing information is available for OMNISCAN (gadodiamide):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for OMNISCAN (gadodiamide):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for OMNISCAN (gadodiamide):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 3 contraindications.
Absolute contraindication.
Contraindication List |
---|
Acute renal failure |
Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min |
Nephrogenic systemic fibrosis |
There are 1 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
Severe List |
---|
Kidney disease with likely reduction in glomerular filtration rate (GFr) |
There are 3 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
Moderate List |
---|
Asthma |
Disease of liver |
Seizure disorder |
The following adverse reaction information is available for OMNISCAN (gadodiamide):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 19 severe adverse reactions.
More Frequent | Less Frequent |
---|---|
None. |
Angioedema Dyspnea Pruritus of skin Skin rash |
Rare/Very Rare |
---|
Abnormal hepatic function tests Acute myocardial infarction Acute pancreatitis Acute renal failure Acute respiratory distress syndrome Anaphylaxis Bronchospastic pulmonary disease Cardiac arrhythmia Chest pain Heart failure Nephrogenic systemic fibrosis Pulmonary edema Seizure disorder Thrombophlebitis Urticaria |
There are 36 less severe adverse reactions.
More Frequent | Less Frequent |
---|---|
Dizziness Headache disorder Nausea |
None. |
Rare/Very Rare |
---|
Acute abdominal pain Acute cognitive impairment Arthralgia Ataxia Black tarry stools Chills Cough Diarrhea Dysgeusia Eructation Fatigue Fever Flushing General weakness Hyperhidrosis Injection site sequelae Loss of taste Malaise Myalgia Pain Paresthesia Pharyngitis Rhinitis Skin plaque Symptoms of anxiety Syncope Tachycardia Tinnitus Tremor Vasodilation of blood vessels Visual changes Vomiting Xerostomia |
The following precautions are available for OMNISCAN (gadodiamide):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
None |
Severe Precaution
None |
Management or Monitoring Precaution
None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for OMNISCAN (gadodiamide):
WARNING: This medication may rarely cause kidney damage. The risk of kidney damage is greater if you already have kidney problems, if you are an older adult, or if you have high blood pressure or diabetes. Your doctor should check how well your kidneys are working before you receive this medication. See also Side Effects section.
WARNING: This medication may rarely cause kidney damage. The risk of kidney damage is greater if you already have kidney problems, if you are an older adult, or if you have high blood pressure or diabetes. Your doctor should check how well your kidneys are working before you receive this medication. See also Side Effects section.
The following icd codes are available for OMNISCAN (gadodiamide)'s list of indications:
No ICD codes found for this drug.
No ICD codes found for this drug.
Formulary Reference Tool